Uri Geiger brings extensive entrepreneurial, management and investment know-how, having created and built many successful medical device enterprises. Until January 2009, Dr. Geiger served as CEO of Exalenz Bioscience Ltd. (TASE:EXEN), developer of an innovative breath-based technology for diagnosing liver and gastrointestinal disorders that was acquired from Oridion Systems (today part of Covidien) and Dr. Geiger took public in 2007.
He previously co-founded and was the CEO of GalayOr Networks, a developer of optical components, sold in 2003 to MEMSCAP (EuroNext: MEMS). Dr. Geiger is also the founding partner of Dragon Variation Fund, one of Israel’s first hedge funds, which was sold to Migdal in 2007. Dr. Geiger worked on Wall Street during the 1990s, where he gained a broad understanding of capital markets and significant experience, which he put to use after returning to Israel in 1999.
Dr. Geiger was formerly an adjunct professor at the Recanati Business School at Tel Aviv University, where he lectured on private equity and venture capital. He is the author of the books: Startup Companies and Venture Capital (Tel Aviv University Press, 2001) and From Concept to Wall Street (Financial Times – Prentice Hall, 2003). He earned his doctorate from New York’s Columbia University Center for Law & Economics, where he majored in global equity markets. Dr. Geiger served as a major in the Israeli Air Force.
James A. D’Orta, MD, is a seasoned business executive, entrepreneur, and physician, with years of leadership experience in both clinical and business settings. Dr. D’Orta is known for his strategic insights and contributions on numerous boards of directors in both the profit and nonprofit sectors; his ability to position new and existing companies for long-term success; and his extensive national and international network of senior-level contacts in business, government, and nonprofits.
Dr. D’Orta most recently served as a Director and Chief Executive Officer of ACell, a Maryland-based medical device manufacturer. Prior to becoming CEO, he served as a member of the Board of Directors and as chairman of the board’s Corporate Governance, Nominating and Compliance Committees.
Prior to ACell, Dr. D’Orta served as the Founder and CEO of Consumer Health Services, Inc., which provided medical support for the walk-in medical clinics in Duane Reed drugstores. Consumer Health Services was acquired by Walgreens in 2013. He formerly was an investor, medical advisor and member of the Board of Directors of Minute Clinic, the walk-in medical clinics which was sold to CVS drugstores.
Earlier, he was founder and CEO of LifeLink MD, providing distribution, training and medical oversight for automated external defibrillators (AEDs), as well as public advocacy and education that helped make AEDS widely available. That company was later sold to Medtronic. In the 1980s, he was a partner in Professional Emergency Physicians (PEP), a group of emergency medical physicians with contracts in several leading hospitals in the DC-Maryland-Virginia region. PEP was later merged into Sterling Health, Inc.
In the 1990s, he served in numerous public service positions, including chairman of the Maryland Governor’s Commission on Emergency Medical Services, which was responsible for keeping Maryland’s emergency medical system at the forefront of such systems nationwide. During this period, he earned honors for his leadership within the medical community and in numerous humanitarian missions.
He currently serves on the Board of Directors of MedStar Health, Inc., the largest provider of acute and in-hospital care within the tri-state area; and he serves on several nonprofit and community service boards.
Darin Hammers was appointed to the Board of Directors and has served as President and CEO of Cogentix Medical since July 2016. Previously Mr. Hammers was interim President and Chief Executive Officer since May 2016, and Senior Vice President of Global Sales & Marketing since August 2013. Mr. Hammers joined Cogentix Medical predecessor company Uroplasty as Vice President of Global Sales in January 2013.
Mr. Hammers’ experience includes over 25 years of increasing leadership roles in urology sales. Prior to joining Uroplasty, Mr. Hammers was Vice President of Sales for Bard Medical Division of C.R. Bard based in Covington, GA, focused on Urology care products. Prior to that, Mr. Hammers spent more than 12 years with Boston Scientific in various sales leadership positions in the Urology/Gynecology areas. Mr. Hammers holds a BS in Marketing from the University of Southern Indiana and an MBA from Emory University.
Cheryl Pegus, M.D., M.P.H is President of Caluent, LLC, a healthcare advisory company. She is a Director and Strategic Advisor of Glytec, a glycemic clinical software organization and Director and Strategic Advisor of HealthFleet, an e-health company. Dr. Pegus is also the President of the American Heart Association (AHA) Founder's Affiliate.
Dr. Pegus has more than 20 years of clinical practice and industry experience. Previously she was the Chief Medical Officer for Walgreens, responsible for Clinical Affairs, Clinical Quality, Outcomes and Analytics, Employee Health and Wellness, and Clinical Sales. She served as the General Manager and Chief Medical Officer for SymCare Personalized Health Solutions, Inc., a J&J start-up company, which provides wireless care management solutions utilizing remote monitoring, now part of the $2.6 billion J&J Diabetes Franchise. Prior to joining SymCare in 2007, she was the Head of Clinical Products for Aetna's Medical Products Business Unit, responsible for developing, prioritizing and articulating the company's clinical product strategy. Former positions at Aetna include National Medical Director, Clinical Program Development/Design and Marketing for Aetna's Member Advantage programs, and National Medical Director for Women's Health. Early in her career, she served as the Medical Director for the Cardiovascular Risk Factors Group at Pfizer Pharmaceuticals in New York.
She is a member of the board of directors of the Founder's Affiliate of the American Heart Association. In addition, Dr. Pegus is a member of the Dean's Circle at Weill Cornell Medical College, sits on the editorial advisory board of Disease Management Advisor , was a Founding Board member of the National Business Group on Health's (NBGH) Obesity Taskforce and is a past board member of the Care Continuum Alliance.
Dr. Pegus is a board-certified physician with subspecialty training in cardiology. She received an M.P.H. from Columbia University School of Public Health, an M.D. from Cornell University Medical College, completed her internal medicine residency and cardiology fellowship at New York Hospital-Cornell and practiced internal medicine and cardiology. She has published many peer-reviewed studies and presented at national and international conferences. Dr. Pegus recently published the healthy cookbook, Everyone Eats.
Lewis Pell has founded over a dozen successful medical technology companies during the past three decades. In 1979, Mr. Pell founded Pentax Precision Instruments, which was sold to Asahi Optical in 1990. In 1983 he founded American Endoscopy Inc., which was sold to CR Bard in 1986. In 1984 he founded Versaflex Inc., which was sold to Medtronic Inc. in 1988. In 1989 he founded Heart Technology Corp., which went public in the U.S. in 1992 and eventually was sold to Boston Scientific in 1995. In 1991 he founded InStent Inc., which became a public company in 1995 and was sold to Medtronic in 1996. In 1994 he founded Influence Inc., which was sold to American Medical Systems Inc. in 1999. Working with Dr. Shlomo Ben-Haim, Mr. Pell founded Biosense Inc. in 1994, which was sold to Johnson and Johnson in 1997. Mr. Pell is currently Chairman and investor in a number of private medical device companies. In 1992 Mr. Pell founded Vision-Sciences, Inc. which merged with Uroplasty in 2015 to become Cogentix Medical. Mr. Pell has a B.S. in Political Science from Brooklyn College
Since October 2014, Mr. Shamir has been the President and Chief Executive Officer of Luminex Corporation. Mr. Shamir previously served, from 2006 to 2014, as President and CEO of Given Imaging, a developer, manufacturer, and marketer of diagnostic products for the visualization and detection of disorders of the gastrointestinal tract. Prior to joining Given Imaging, Mr. Shamir was Corporate Vice President of Eastman Kodak Company and President of Eastman Kodak´s Transaction and Industrial Solutions Group. Additionally, he served over 10 years at Scitex Corporation in positions of increasing responsibility, including President and CEO from 2003 to 2004. Prior to Scitex Corporation, Mr. Shamir held senior management positions at various international companies mainly in the Asia Pacific regions. Mr. Shamir currently serves on the board of directors of Invendo Medical GmbH. Mr. Shamir holds a Bachelor of Science from the Hebrew University of Jerusalem and a Masters of Public Administration from Harvard University.
Kenneth A. Samet, FACHE, is President and Chief Executive Officer of MedStar Health, a $5 billion not-for-profit, healthcare delivery system comprised of 10 hospitals, a comprehensive network of health-related businesses that includes research, ambulatory, home health, and a large multi-specialty physician network, and several insurance products with more than 170,000 members.
Mr. Samet has dedicated his career to health care. From 2003 to 2008, he served as president and chief operating officer of MedStar Health, and prior to that, served as the system’s first chief operating officer since MedStar’s inception in 1998. Mr. Samet served as president of MedStar Washington Hospital Center, one of the nation’s largest tertiary care hospitals, in the District of Columbia from 1990 to 2000. From the mid-1980s to 1990, Mr. Samet held a variety of leadership positions with the Medlantic Healthcare Group, which merged with Helix Health in 1998 to create MedStar Health.
Mr. Samet is presently a member of the board of directors at Georgetown University, the Greater Baltimore Committee, the Economic Club of Washington, United Way of the National Capital Area, Goodwill of Greater Washington and serves on the Executive Committee of the board of the Greater Washington Board of Trade. Samet presently serves on the Board of Evolent Health (EVH) and served for seven years on the Board of Catalyst Health Solutions (CHSI), a pharmacy benefit management company. Mr. Samet is also a past board member and chair of the Academic Affairs Committee of the Old Dominion University Board of Visitors, where he received his bachelor’s degree in business administration in 1980 and an honorary doctorate of humane letters in 2012. Mr. Samet received his master’s degree in health services administration from the University of Michigan in 1982.
Mr. Zauberman has over 30 years of experience as a leader in the medical products industry and was most recently CEO of Vision Sciences prior to the merger with Uroplasty in April 2015. Prior to joining the Company, Mr. Zauberman was Vice President of Business Development at Henry Schein, Inc., a leading global healthcare distributor serving office based medical practitioners, from 2005 through 2012. Mr. Zauberman also served as a Special Venture Partner at Galen Partners, a healthcare growth equity and late stage venture capital firm, focused on technology enabled services, medical devices and specialty pharmaceuticals. Prior to this, Mr. Zauberman held senior management positions at ETHICON, Inc. a Johnson & Johnson company and Pfizer, Inc. Mr. Zauberman has a Masters of Engineering Management from Northwestern University, a Bachelor of Science from Columbia University in mechanical engineering and a Bachelor’s degree from Queens College.